Yousof Gheisari

Yousof Gheisari is focused on developing novel therapeutics for chronic kidney disease, with a particular emphasis on diabetic kidney disease. To achieve this goal, his research group uses systems biology and artificial intelligence approaches for multi-omics analysis, big-data integration, large-scale dynamic modeling, drug-target prioritization, in-silico lead generation, and drug repurposing. Predictions from these pipelines are subsequently assessed in preclinical models. The interdisciplinary team combines expertise in experimental biology, computational biology, control engineering, artificial intelligence, pharmaceutical chemistry, and clinical medicine.